WS #10413

The dominant signal in this window is a confluence of positive geopolitical developments and major M&A activity, offsetting the ongoing UK political transition. Vice President Vance confirmed that US-Iran talks made 'a lot of good progress,' with Iran agreeing to invite IAEA inspectors back and the Strait of Hormuz remaining open. This directly counters the prevailing oil supply crisis narrative, sending oil prices lower and providing a tailwind for risk assets. Separately, AbbVie announced a $10.9 billion all-cash acquisition of Apogee Therapeutics at a ~60% premium, resetting the biotech tape. CRH agreed to acquire Arcosa for $150/share in an $8.5 billion deal, strengthening its North American infrastructure position. Former Fed Chair Alan Greenspan passed away at 100, a notable but non-market-moving event. The UK political crisis (Starmer resignation, Burnham candidacy) remains stable with no new material developments. The narrative arc is DE-ESCALATING on geopolitical risk, with the US-Iran progress acting as a counter-signal to the oil/bearish macro thesis.